He continued: «We can conclude from this analysis that the use of G - CSF during thoracic radiotherapy is safe and should support patients to receive the full planned course of concurrent chemo - radiotherapy and achieve the best possible benefit.
A late breaking subanalysis of the phase III CONVERT trial presented at the European Lung Cancer Conference (ELCC) shows that white blood cell boosting drugs are safeduring concurrent chemo - radiotherapy of small cell lung cancer (SCLC).